Commonwealth Equity Services, LLC Veracyte, Inc. Transaction History

Commonwealth Equity Services, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 04, 2022	SELL	$21.94 - $42.51 $195,814 - $379,401	-8,925 Closed	0 $0
Q4 2021 Jan 31, 2022	BUY	$36.09 - $53.79 $7,218 - $10,758	200 Added 2.29%	8,925 $367,000
Q3 2021 Oct 29, 2021	BUY	$35.62 - $52.97 $29,742 - $44,229	835 Added 10.58%	8,725 $405,000
Q2 2021 Aug 11, 2021	BUY	$32.94 - $56.62 $29,843 - $51,297	906 Added 12.97%	7,890 $315,000
Q1 2021 May 04, 2021	BUY	$44.47 - $81.38 $95,210 - $174,234	2,141 Added 44.21%	6,984 $375,000
Q4 2020 Feb 11, 2021	BUY	$32.49 - $61.88 $157,349 - $299,684	4,843 New	4,843 $237,000

307

81.6M

134K

13.3K

Ticker VCYT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,575,904
Market Cap $2.97B
Description
Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...

Get notified when there are updates to the investment portfolio of Commonwealth Equity Services, LLC, based on Form 13F filings with the SEC.

Stay updated on Commonwealth Equity Services, LLC with notifications on news.